Drug addiction is now viewed as a brain disease. Understanding the biological basis of substance is needed to develop specific treatment paradigms. The consequences of drug addiction are especially noted in inner city neighborhoods, like the Watts/Willowbrook section of Los Angeles -the catchment area for King/Drew Medical Center. Since addiction is such a complex and devastating illness, a committed public health approach, including education, prevention, treatment and research is needed. Drew University is committed to improvement of the infrastructure needed for substance abuse research, education and treatment. Drew University is well funded for non-substance abuse research and there is a high investigator interest in substance abuse research, yet NIH applications related to drug abuse are deficient. Similar, education on the importance of substance abuse and substance abuse research is lacking on campus. The MIDARP program will provide support to develop the infrastructure needed for substance abuse research at Drew. Thus, the goals of this MIDARP application are to: (1) develop the drug abuse research at Drew; (2) provide research development support and experiences to faculty and staff to facilitate independent drug abuse research careers, (3) foster interest in drug abuse research for students and residents and provide them research experiences, and 4) provide for continued drug abuse research funded by NIDA or other agencies. We will specifically encourage the development of minority faculty and students. The theme of the training and incorporate expertise at Drew The goals of the two research science level and to understand in the reinforcing and addictive projects are to understand the mechanisms of the mechanisms of how the endogenous opioid properties of cocaine.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Resource-Related Research Projects (R24)
Project #
3R24DA017298-02S3
Application #
7494900
Study Section
Special Emphasis Panel (ZDA1-EXL-T (23))
Program Officer
Purohit, Vishnudutt
Project Start
2004-09-15
Project End
2008-04-30
Budget Start
2005-09-01
Budget End
2008-04-30
Support Year
2
Fiscal Year
2007
Total Cost
$61,553
Indirect Cost
Name
Charles R. Drew University of Medicine & Science
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Liu, Limei; Wang, Ying; Wang, Jian et al. (2018) Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced visceral adiposity. Int J Obes (Lond) 42:1999-2011
Sinha-Hikim, Amiya P; Mahata, Sushil K (2018) Editorial: Obesity, Smoking, and Fatty Liver Disease. Front Endocrinol (Lausanne) 9:1
Hasan, Mohammad Kamrul; Friedman, Theodore C; Sims, Carl et al. (2018) ?7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling. Endocrinology 159:931-944
Kermah, Dulcie; Shaheen, Magda; Pan, Deyu et al. (2017) Association between secondhand smoke and obesity and glucose abnormalities: data from the National Health and Nutrition Examination Survey (NHANES 1999-2010). BMJ Open Diabetes Res Care 5:e000324
Tang, Kechun; Pasqua, Teresa; Biswas, Angshuman et al. (2017) Muscle injury, impaired muscle function and insulin resistance in Chromogranin A-knockout mice. J Endocrinol 232:137-153
Sinha-Hikim, Indrani; Friedman, Theodore C; Falz, Mark et al. (2017) Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis. Cell Tissue Res 368:159-170
Lutfy, K; Parikh, D; Lee, D L et al. (2016) Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence. Neuroscience 329:318-25
Harris, Kindred K; Zopey, Mohan; Friedman, Theodore C (2016) Metabolic effects of smoking cessation. Nat Rev Endocrinol 12:299-308
Yan, C; Yang, H; Wang, Y et al. (2016) Increased glycogen synthase kinase-3? and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity. Int J Obes (Lond) 40:1233-41
Wang, Ying; Yan, Chaoying; Liu, Limei et al. (2015) 11?-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue. Am J Physiol Endocrinol Metab 308:E84-95

Showing the most recent 10 out of 49 publications